TEVA
LOW Impact
TEVA
Teva Pharmaceutical Announces Third Quarter 2025 Financial Results
|
8-K
Summary
Teva Pharmaceutical Industries Ltd. has announced its financial results for the third quarter of 2025, with specific details to be found in the furnished press release. The announcement serves as a regulatory update and does not include detailed financial metrics within the 8-K filing itself.
Profitelligence Alerts
Get alerts for TEVA
Be first to know when TEVA files with the SEC.
Filing Categories
General Statement
Exhibits Furnished
Advertisement
Official SEC Documents
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement